TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 2.5nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 49nMAssay Description:In vitro inhibition of human alphaV-beta3 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 300nMAssay Description:In vitro inhibition of human alphaV-beta3 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 330nMAssay Description:In vitro inhibition of human alphaV-beta3 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 420nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 470nMAssay Description:In vitro inhibition of human alphaV-beta3 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 7.80E+3nMAssay Description:In vitro inhibition of human alpha5-beta1 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:In vitro inhibition of human alpha5-beta1 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:In vitro inhibition of human alpha5-beta1 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:In vitro inhibition of human alpha5-beta1 integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:In vitro inhibition of human alphaIIb betaIIIa integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:In vitro inhibition of human alphaIIb betaIIIa integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:In vitro inhibition of human alphaIIb betaIIIa integrin binding in ELISAMore data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:In vitro inhibition of human alphaIIb betaIIIa integrin binding in ELISAMore data for this Ligand-Target Pair